Home » Trials » SLCTR/2008/017


Zinc status in patients with diabetes mellitus and efficacy of multi mineral supplementation on glycaemic control with special reference to zinc

-

SLCTR Registration Number

SLCTR/2008/017


Date of Registration

22 Aug 2008

The date of last modification

Mar 03, 2019


Trial Status



Application Summary


Scientific Title of Trial

Zinc status in patients with diabetes mellitus and efficacy of multi mineral supplementation on glycaemic control with special reference to zinc


Public Title of Trial

Effect of zinc on sugar control among diabetes


Disease or Health Condition(s) Studied

Diabetes Mellitus


Scientific Acronym

None


Public Acronym

None


Brief title

None


Universal Trial Number

None


Any other number(s) assigned to the trial and issuing authority

None


Trial Details


What is the research question being addressed?

  1. Are the serum zinc levels in type II diabetes patients lower than age/ sex matched healthy controls?
  2. Is the urinary zinc excretion in type II diabetes patients higher than age/sex matched healthy controls
  3. Will the addition of zinc to mineral/vitamin supplementation improve the glycaemic control among typeII diabetic patients

Type of study

Interventional


Study design

Allocation

Randomized controlled trial


Masking

Masking not used


Control

Placebo


Assignment

Parallel


Purpose

Treatment


Study Phase

Not Available


Intervention(s) planned

The diabetic patients will be chosen from patients attending the medical clinics of the Teaching Hospital, Karapitiya 1. Diabetes patients will be stratified by sex, age and duration of treatment and randomly assigned to one of three treatment groups 2. Group A will be supplemented with oral zinc sulfate (22mg of elemental zinc/day) and multivitamin/mineral preparation (vitamin A, Vitamin D3, Vitamin E, magnesium, manganese, copper and selenium) 3. Group B will be supplemented with same preparation but without zinc 4. Group C will be supplemented with placebo and designed as a control group 5.Depending upon the treatment groups, each subject will receive one tablet per day for a period of 4 months 6. A questionnaire on social demography will be administered and 24 hour dietary intake will be recorded 7. Their anthropometry and blood pressure will be recorded 8. Following investigations will be done at the study entry and at the end of the follow-up Fasting blood sugar a.Post prandial blood sugar b.HbA1c c.Serum creatinine d.Serum zinc e.Urinary zinc f.Urinary creatinine


Inclusion criteria

  1. not taking vitamin and/or mineral supplements, thyroid hormones, estrogen or progesterone
  2. having no history of a recent surgery or acute infection
  3. women, not being pregnant or lactating

Exclusion criteria

Diabetes patients who are on insulin preparations as part of diabetic management



Primary outcome(s)

1.

Improvement in glycaemic control by multi mineral/vitamin supplementation

[

At the end of the study: June 2009

]

Secondary outcome(s)

1.

•Improving awareness on proper blood sugar control among diabetes patients •Improving awareness on general nutritional status of the diabetes patients

[

Throughout the research programme i.e., July 2008 to June 2009

]

Target number/sample size

75


Countries of recruitment

Sri Lanka


Anticipated start date

2008-09-01


Anticipated end date

2009-04-30


Date of first enrollment

2008-12-01


Date of study completion


Recruitment status

Complete: follow up complete


Funding source

International Atomic Energy Agency (IAEA)


Regulatory approvals



State of Ethics Review Approval


Status

Approved


Date of Approval

2008-04-01


Approval number

Not Available


Details of Ethics Review Committee

Name: Ethics Review Committee, Faculty of Medicine, University of Ruhuna
Institutional Address:PO Box 70, Labuduwa Rd, Galle, Sri Lanka
Telephone:+94-91-2234801/803 (Extension: 161)
Email: ethics@med.ruh.ac.lk

Contact & Sponsor Information


Contact person for Scientific Queries/Principal Investigator

Prof. Sarath Lekamwasam
Professor in Medicine
Department of Medicine, Faculty of Medicine, P.O. Box 70, Karapitiya, Galle
912234801

912222314
sarathlk@sltnet.lk

Contact Person for Public Queries

Dr. ILPR Gunasekara
Senior Medical Officer
Coronary Care Unit, Teaching Hospital, Karapitiya, Galle

777792787
912222314
nmu_galle@yahoo.com


Primary study sponsor/organization

A. Baur & Co. Ltd

Healthcare Division, 62, Jethawana Road, Colombo 14
114728784
112473258
nalindra@baurs.com

Secondary study sponsor (If any)

None





Trial Completion details


Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?


IPD sharing plan description

Not Available


Study protocol available


Protocol version and date

Not Available


Protocol URL

Not Available


Results summary available

No


Date of posting results


Date of study completion


Final sample size


Date of first publication


Link to results


Brief summary of results